Acrivon Therapeutics, Stock Forecast - Simple Exponential Smoothing

ACRV Stock   7.87  0.12  1.55%   
The Simple Exponential Smoothing forecasted value of Acrivon Therapeutics, Common on the next trading day is expected to be 7.87 with a mean absolute deviation of 0.28 and the sum of the absolute errors of 16.58. Acrivon Stock Forecast is based on your current time horizon.
  
Payables Turnover is likely to drop to 0.10 in 2024. Common Stock Shares Outstanding is likely to climb to about 23.6 M in 2024, whereas Net Loss is likely to drop (29.5 M) in 2024.
Most investors in Acrivon Therapeutics, cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Acrivon Therapeutics,'s time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Acrivon Therapeutics,'s price structures and extracts relationships that further increase the accuracy of the generated results. Acrivon Therapeutics, simple exponential smoothing forecast is a very popular model used to produce a smoothed price series. Whereas in simple Moving Average models the past observations for Acrivon Therapeutics, Common are weighted equally, Exponential Smoothing assigns exponentially decreasing weights as Acrivon Therapeutics, prices get older.

Acrivon Therapeutics, Simple Exponential Smoothing Price Forecast For the 19th of October

Given 90 days horizon, the Simple Exponential Smoothing forecasted value of Acrivon Therapeutics, Common on the next trading day is expected to be 7.87 with a mean absolute deviation of 0.28, mean absolute percentage error of 0.14, and the sum of the absolute errors of 16.58.
Please note that although there have been many attempts to predict Acrivon Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Acrivon Therapeutics,'s next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Acrivon Therapeutics, Stock Forecast Pattern

Backtest Acrivon Therapeutics,Acrivon Therapeutics, Price PredictionBuy or Sell Advice 

Acrivon Therapeutics, Forecasted Value

In the context of forecasting Acrivon Therapeutics,'s Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Acrivon Therapeutics,'s downside and upside margins for the forecasting period are 3.43 and 12.31, respectively. We have considered Acrivon Therapeutics,'s daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
7.87
7.87
Expected Value
12.31
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Simple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Acrivon Therapeutics, stock data series using in forecasting. Note that when a statistical model is used to represent Acrivon Therapeutics, stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria114.2937
BiasArithmetic mean of the errors 0.0083
MADMean absolute deviation0.2763
MAPEMean absolute percentage error0.0336
SAESum of the absolute errors16.58
This simple exponential smoothing model begins by setting Acrivon Therapeutics, Common forecast for the second period equal to the observation of the first period. In other words, recent Acrivon Therapeutics, observations are given relatively more weight in forecasting than the older observations.

Predictive Modules for Acrivon Therapeutics,

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Acrivon Therapeutics,. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Acrivon Therapeutics,'s price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
3.457.8712.29
Details
Intrinsic
Valuation
LowRealHigh
6.9411.3615.78
Details
10 Analysts
Consensus
LowTargetHigh
21.0523.1325.67
Details

Other Forecasting Options for Acrivon Therapeutics,

For every potential investor in Acrivon, whether a beginner or expert, Acrivon Therapeutics,'s price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Acrivon Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Acrivon. Basic forecasting techniques help filter out the noise by identifying Acrivon Therapeutics,'s price trends.

Acrivon Therapeutics, Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Acrivon Therapeutics, stock to make a market-neutral strategy. Peer analysis of Acrivon Therapeutics, could also be used in its relative valuation, which is a method of valuing Acrivon Therapeutics, by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Acrivon Therapeutics, Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Acrivon Therapeutics,'s price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Acrivon Therapeutics,'s current price.

Acrivon Therapeutics, Market Strength Events

Market strength indicators help investors to evaluate how Acrivon Therapeutics, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Acrivon Therapeutics, shares will generate the highest return on investment. By undertsting and applying Acrivon Therapeutics, stock market strength indicators, traders can identify Acrivon Therapeutics, Common entry and exit signals to maximize returns.

Acrivon Therapeutics, Risk Indicators

The analysis of Acrivon Therapeutics,'s basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Acrivon Therapeutics,'s investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting acrivon stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Acrivon Stock Analysis

When running Acrivon Therapeutics,'s price analysis, check to measure Acrivon Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acrivon Therapeutics, is operating at the current time. Most of Acrivon Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of Acrivon Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acrivon Therapeutics,'s price. Additionally, you may evaluate how the addition of Acrivon Therapeutics, to your portfolios can decrease your overall portfolio volatility.